ADHD Awareness Month

United States, Canada, United Kingdom, Australia, Ireland, New Zealand

About

ADHD Awareness Month is observed throughout October as a time to increase understanding of attention-deficit/hyperactivity disorder (ADHD) and recognize the many ways it can affect people’s lives. The observance helps share accurate information, challenge misconceptions, and highlight that ADHD can occur in children, teenagers, and adults. It also celebrates the diverse strengths, creativity, energy, and perspectives often associated with people who have ADHD.

Throughout the month, communities, schools, workplaces, healthcare professionals, and families are encouraged to promote compassion and support. ADHD Awareness Month offers an opportunity to learn about diagnosis and treatment, appreciate individual experiences, and advocate for accommodations that help people thrive. By encouraging open conversations and reducing stigma, the observance reminds everyone that understanding and acceptance can make a meaningful difference.

History

ADHD Awareness Month is observed throughout October to increase understanding of attention-deficit/hyperactivity disorder (ADHD), a neurodevelopmental condition that can affect attention regulation, impulse control, activity level, executive functioning, and emotional regulation. The observance developed from longstanding efforts by advocacy and professional organizations to replace misconceptions about ADHD with accurate information. In the United States, organizations including Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD), the Attention Deficit Disorder Association (ADDA), and the ADHD Coaches Organization helped establish a coordinated annual awareness effort in 2004.

Its origins reflect a period when public discussion of ADHD was expanding beyond childhood behavior in school. Advocates emphasized that ADHD can continue through adolescence and adulthood and may influence education, employment, relationships, finances, and daily organization. The observance also sought to counter stigmatizing ideas that ADHD resulted simply from laziness, poor discipline, or inadequate parenting. By promoting medically and scientifically informed explanations, ADHD Awareness Month gave families, educators, clinicians, and affected individuals a shared opportunity to discuss diagnosis, treatment, accommodations, and practical support.

Over time, the observance evolved from a largely awareness-focused campaign into a broader platform for education and advocacy. Information shared during October commonly addresses the different ways ADHD may appear, including predominantly inattentive, hyperactive-impulsive, or combined presentations, while recognizing that symptoms and challenges vary considerably from person to person. Campaigns increasingly include adults, women and girls, people from historically underdiagnosed communities, and individuals whose ADHD was not identified until later in life. They also highlight evidence-based supports, such as behavioral strategies, educational and workplace accommodations, psychotherapy, coaching, and, when appropriate, prescribed medication.

Culturally, ADHD Awareness Month has helped encourage more open conversations about neurodiversity, disability rights, and the importance of reducing stigma. It provides a time for people with ADHD and their families to share experiences, while reminding the wider public that the condition is real, multifaceted, and not defined by stereotypes. Throughout October, schools, health organizations, advocacy groups, workplaces, and online communities may use the observance to distribute reliable resources, encourage evaluation by qualified professionals, and promote environments that recognize both the challenges and strengths associated with ADHD.

Timeline

1902
British pediatrician Sir George Frederic Still delivered lectures describing children with serious problems of attention, impulsivity, and self-control; his work is widely regarded as an early clinical description of what is now understood as ADHD.
1937
Psychiatrist Charles Bradley reported that the stimulant Benzedrine improved behavior and school performance in some children with behavioral difficulties, an important early finding in stimulant treatment for ADHD-related symptoms.
1980
The American Psychiatric Association's DSM-III introduced the diagnosis “attention deficit disorder” (ADD), with and without hyperactivity.
1987
DSM-III-R replaced ADD terminology with “attention-deficit hyperactivity disorder” (ADHD), establishing the name now used for the condition.
1994
DSM-IV defined ADHD presentations as predominantly inattentive, predominantly hyperactive-impulsive, and combined types, shaping diagnosis and research for many years.

Upcoming dates

Sources

Same day

Related